Atlas Trials

Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B

Clinical trial NCT04850950 · UNKNOWN

Trial details

NCT number
NCT04850950
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis BMother-to-Child TransmissionSafetyEfficacyHepatitis B VirusTenofovir Alafenamide Fumarate
Start date
2021-04-26
Primary completion
2022-12-31
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.